Hearing Health Equity Through Accessible Research and Solutions for Korean Americans (K-HEARS)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Carrie L Nieman, MD, MPH
- Phone Number: 410-502-6965
- Email: cnieman1@jhmi.edu
Study Contact Backup
- Name: Hae-Ra Han, PhD, RN
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21205
- Johns Hopkins School of Nursing
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
PARTICIPANT CRITERIA Participant inclusion criteria
- Self-identified as first-generation KA in the target region
- Age 60 years or older
- Has a communication partner who lives in the same household or has at least weekly interactions
- Screening audiometry Pure-tone audiometry (PTA)1,2,4 kilohertz (kHz) >25 decibel (dB) hearing loss (HL) in better ear
- Hearing handicap as measured by HHIE-S score >=8 Participant exclusion criteria
- Current use of hearing aid
- Medical contraindications to use amplification device (e.g., draining ear)
- Plan to move from the area within 6 months
- Active treatment for a terminal illness or in hospice
COMMUNICATION PARTNER CRITERIA Communication Partner inclusion criteria
- Age 18 years or older
- Able to read and speak Korean
- Lives with the older adult or has at least weekly interactions Communication Partner exclusion criteria
- Plan to move from the area within 6 months
- Active treatment for a terminal illness or in hospice
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Immediate Treatment Site
Study site assigned to immediate treatment of K-HEARS intervention
|
Tailored aural rehabilitation for participant and care partner
Tailored fitting and programming of a personal sound amplifier.
This will be accompanied by a component of aural rehabilitation.
|
|
Placebo Comparator: Delayed Treatment Site
Study site assigned to 6-month delayed treatment of K-HEARS intervention
|
Tailored aural rehabilitation for participant and care partner
Tailored fitting and programming of a personal sound amplifier.
This will be accompanied by a component of aural rehabilitation.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hearing Handicap Inventory for the Elderly (HHIE-S) score
Time Frame: Baseline, 6 months post-intervention (Immediate Group). 6 months post-baseline (Delayed Group)
|
Score range 0-40.
0-8 suggests no hearing handicap 10-24 suggests mild-moderate hearing handicap 26-40 suggests significant hearing handicap.
|
Baseline, 6 months post-intervention (Immediate Group). 6 months post-baseline (Delayed Group)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Third Party Disability as assessed by the Significant Other Scale for Hearing Disability (SOS-HEAR)
Time Frame: Baseline, 6 months post-intervention (Immediate Group). 6 months post-baseline (Delayed Group)
|
Third-party disability will be measured in communication partners using the Significant Other Scale for Hearing Disability (SOS-HEAR).
Score range 0-104, with higher score more disability.
|
Baseline, 6 months post-intervention (Immediate Group). 6 months post-baseline (Delayed Group)
|
|
Relationship Quality as assessed by the Mutuality Scale
Time Frame: Baseline, 6 months post-intervention (Immediate Group). 6 months post-baseline (Delayed Group)
|
Relationship quality will be measured using the Mutuality Scale among participants and communication partners.
Score range 0-60, with higher score better relationship quality.
|
Baseline, 6 months post-intervention (Immediate Group). 6 months post-baseline (Delayed Group)
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Hae-Ra Han, PhD,RN, Johns Hopkins University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- IRB00406742
- R01DC019686 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.